Segments - Global Drug Transfer Device Market by Types (Membrane-to-Membrane Systems and Needleless Systems), Components (Closed Bag/Line Access Devices, Closed Vial Access Devices, and Closed Syringe Safety Devices), Technology (Diaphragm-Based Devices, Compartmentalized Devices, and Air Cleaning/Filtration Devices), End-users (Specialty Centers, Hospitals, Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 - 2027
The global drug transfer device market was valued at USD 392.6 Mn in 2019 and is projected to reach USD 1,767.4 Mn by 2027, expanding at a CAGR of 21.2% during the forecast period. The market is driven by the rising number of cancer cases and increasing adoption of chemotherapy are anticipated to drive the demand for the drug transfer device market. Growth of drug transfer devices is attributed to combat the harmful effects of antineoplastic drugs.
Drug transfer device mechanically forbids the transfer of environmental impurities into the system and the escape of the hazardous drug. The drug transfer devices are those which prevent drug leak at the time of patient treatment. The drug leak can take place at the time of reconstitution, administration of the drug to the patient or compounding.
Pharmacists, physicians, nurses, and other healthcare workers come in contact with several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics during cancer treatments. Adoption of drug transfer devices has witnessed growth, as it reduces surface contamination and closes routes of exposure.
Drug transfer devices are devices designed to prevent the transfer of contaminants into the environment during drug transfer between the vial and syringe, by maintaining a closed connection. Rising number of cancer cases and increasing adoption of chemotherapy are anticipated to drive the demand for the drug transfer device market.
Pharmacists, physicians, nurses, and other healthcare workers come in contact with several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics during cancer treatments. Traces of these drugs have been found in unlikely places like doorknobs, keyboards, and other surfaces. It also affects the patients and their families and other hospital staff.
Recent discoveries in cancer and oncology has led to new treatment approaches and drugs. Yet cancer exists with unmet medical needs. Regulatory authorities such as the FDA have now begun to show flexibility towards the approval of drugs and have come up with new and creative ways of measuring the suitability of cancer drugs. This has led to a substantial surge in the speed of approval of new drugs.
Vial adaptor is a drug transfer device that connects vial to syringe or vial to vial, enabling the mixing and/or transfer of the drug (to be administered to the patient thereafter). Although there are many ISO standards for infusion transfer devices, these do not necessarily apply to vial adaptors. When healthcare sites criticize about issues with vial adaptors, no standards exist to support the issues. Vial adaptor manufacturers want to design products that achieve user and patient safety, but lack quantitative specifications to test their devices in real-world conditions.
Hence, lack of detailed guidelines and inefficiency of drug transfer products especially in emerging nations and restrain the market. According to National Medical Products Administration, around 10 million healthcare personnel in China are exposed to hazardous drugs annually, due to lack of government policies and proper guidelines regarding drug transfer devices.
Drug transfer devices are additional engineering controls designed to reduce occupational exposure of hazardous drugs. They are constantly implemented in accordance with changing regulations. A significant number of drug transfer devices are now commercially available. They comprise different materials of construction, lubricants, fluid path, and holdup volumes.
A detailed compatibility study with each type of commercial drug transfer device and investigational drug products is difficult and significantly extends timelines for product development. Health authority feedback regarding the use of drug transfer devices for investigational drug products is needed to ensure compliance, especially for patient safety while balancing risk and benefit to the health care personnel. This is expected to provide opportunities for market growth.
Based on types, the global drug transfer device market is segmented into membrane-to-membrane systems and needleless systems. The membrane-to-membrane segment is expected to grow at a significant rate during the forecast period. The presence of double membrane for transfusion of medication provides an added layer of protection compared to needleless membranes, which fuels the membrane-to-membrane segment.
In terms of components, the global drug transfer device market is segmented into closed bag/line access devices, closed vial access devices, and closed syringe safety devices. The closed vial access devices segment is estimated to expand during the forecast period. Closed vial access devices help in storing a drug for up to a week. The closed vial access device segment is expected to grow at a substantial pace during the forecast period.
Based on technologies, the global drug transfer device market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. The diaphragm-based devices segment is anticipated to expand at a significant pace in the coming years. The diaphragm-based devices segment dominated the market during 2019 and held a key share of the market.
The segment is projected to expand at a considerable pace during the forecast period owing to the safety provided by these device and ease of operation. The compartmentalized devices segment is estimated to expand at a rapid pace due to its cost-effectiveness.
In terms of end-users, the global drug transfer device market is segregated into specialty centers, hospitals, clinics, and others. The hospitals segment is expected to lead the market during forecast, as patients prefer to visit hospitals due to the presence of doctors and medical staff and equipment for treatment under one roof. Accessibility of diagnostic centers in the clinic is helpful for patients as they can be diagnosed and tested at the same place. The clinics are less expensive.
However, non-availability of services 24*7 may hinder the growth of clinic segment in the drug transfer device market. The specialty centers segment is likely to expand at a significant pace owing to the rise in pulmonary diseases, cancers, and hormonal disorders. The specialty center segment is estimated to expand with a substantial CAGR during the forecast period.
On the basis of regions, the global drug transfer device market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds a major share of the market and this trend is expected to continue during the forecast period. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period.
The growth of the market in Asia Pacific is attributed to the increasing number of cancer cases and rising demand for improved healthcare services in developing countries such as China and India. The drug transfer devices market is projected to grow due to technological advancements, investments in research & development, and rising awareness about the DTDs among people.
Major Manufactures are B. Braun Medical Inc., BD, Equashield LLC., ICU Medical, Inc., and JMS Co Ltd.
The base year considered for the global drug transfer device market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.
COVID- 19 has several positive and negative impacts on the world economy. Economic activities have come to a stand-still, as countries imposed harsh restrictions to curb the spread of coronavirus. This has left a long-lasting damage on the world economy.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The market is driven by the increasing use of chemotherapy in cancer patients, and high demand for administration of antineoplastic drugs.
The applications in the global drug transfer device market includes Specialty Centers, Hospitals, Clinics, and Others
In addition to market size (in USD Million) & market volume (in Mn Units), company market share (in % for base year 2019), other data such as regulatory outlook, Medical Devices Industry Outlook, macro-economic factors and COVID-19 impact on the value chain are available in the final report.
According to the Growth Market Reports, the market for drug transfer device is likely to register a CAGR of 21.2% during forecast period 2020-2027, with an anticipated valuation of USD 1,767.4 million by the end of 2027.
Yes, the report provides supply chain analysis along with a list of raw material suppliers, manufacturers, distributors, and customers.
Additional company profiles can be provided on request.